Company Filing History:
Years Active: 2022-2024
Title: Mahesh Padval: Innovating in Calcium Channel Modulation
Introduction
Mahesh Padval, an accomplished inventor based in Cambridge, MA, has made significant strides in the pharmaceutical field with his innovative research. He holds two patents that contribute to the understanding and treatment of disorders related to T-type calcium channels.
Latest Patents
Padval’s latest patent focuses on the "Formulations of T-type calcium channel modulators and methods of use thereof." This invention details dosage forms and compositions that aim to prevent and treat diseases associated with aberrant T-type calcium channel functions, including various forms of epilepsy, tremors, and psychiatric disorders such as major depressive disorder. The patent also encompasses methods for modulating the T-type calcium channel's function, paving the way for novel therapeutic options for patients suffering from these conditions.
Career Highlights
Mahesh Padval works with Praxis Precision Medicines, Inc., where he applies his expertise in medicinal chemistry and pharmacology to develop groundbreaking treatments. His work emphasizes the potential of modulating calcium channels to alleviate neurological and psychiatric ailments, demonstrating his commitment to advancing healthcare solutions.
Collaborations
Throughout his career, Padval has collaborated with esteemed colleagues such as Kiran Reddy and Margaret S. Lee. Together, they have contributed to several innovative projects that explore the intersection of pharmacology and neurology, further enriching the research conducted at their company.
Conclusion
Mahesh Padval stands out as a notable inventor whose work in T-type calcium channel modulation represents a significant leap forward in treating prevalent neurological disorders. His patents not only reflect his innovative spirit but also highlight the collaborative nature of modern scientific research, aiming for impactful advancements in patient care.